Last updated: March 10, 2026
What is the scope of patent CY1126143?
Patent CY1126143 pertains to a pharmaceutical compound or formulation, primarily targeting a specific disease or condition, often related to a novel chemical entity or a new use of an existing compound. The patent's scope is defined by its claims, which specify the protected subject matter.
The patent claims generally cover:
- The chemical composition or compound as synthesized.
- Methods of manufacture or synthesis of the compound.
- Medical uses of the compound, such as treating, preventing, or diagnosing a specific disease.
- Possible formulations, delivery mechanisms, or dosage forms.
Given the details available from CY1126143, its scope is likely confined to the specific chemical structure claimed, with claims extending to its pharmaceutical composition, methods of production, and therapeutic applications.
How broad are the claims within CY1126143?
The breadth of the claims influences the patent's strength and freedom-to-operate analysis. Without direct access to the full patent document, the typical structure involves:
- Independent claims: Define the core invention, often covering the chemical structure(s) or use in treatment.
- Dependent claims: Narrow down the independent claims, adding specific details such as particular substituents, formulations, or dosing parameters.
The claims usually indicate whether the patent covers:
- A class of compounds (e.g., a chemical family with variable side chains).
- A specific compound (single structure).
- Use claims, such as treatment of particular diseases with the compound.
- Manufacturing methods for synthesis or formulation techniques.
In the case of CY1126143, if the claims include broad classes of compounds, the patent's scope becomes more comprehensive but potentially more vulnerable to invalidation based on prior art.
How does CY1126143 fit into the patent landscape?
The patent landscape surrounding CY1126143 depends on prior art, related patents, and active patent filings in relevant jurisdictions. Critical factors include:
- Prior art searches: Determine if the compound or its uses have been disclosed previously.
- Related patents: Similar patents might exist covering chemical structures, methods, or therapeutic uses.
- Patents filed in other jurisdictions: Key pharmaceutical patents often have equivalents or continuations in major markets such as the US, EU, and China.
A landscape analysis shows active patenting in related spaces often involves:
- Patents on similar chemical classes or therapeutic targets.
- Patent families covering formulations, combinations, or delivery methods.
- "Blocking patents" aimed at protecting core compounds or uses.
Patent strategy implications
CY1126143's scope suggests a strategic focus on a specific chemical entity or therapeutic application. Its coverage depends on whether the claims are narrow (specific compound/use) or broad (chemical class/use combination).
- Broad claims can provide extensive market protection but are more susceptible to prior art challenges.
- Narrow claims might offer less immediate scope but can be strong if well supported by data and inventive step.
Future patent landscape considerations
- Patent expiration timelines: Most patents have an life span of 20 years from the filing date. The status of CY1126143 (pending, granted, or expired) impacts market exclusivity.
- Patent filing strategies: Filing continuations or divisional applications can extend protection or cover new uses.
- Market competition: Identify patents in similar therapeutic areas or chemical classes to assess potential patent overlaps or freedom-to-operate issues.
Conclusions
Patent CY1126143 appears to claim a specific chemical entity or its application within a well-defined therapeutic area. Its strength depends on claim breadth, prior art novelty, and jurisdictional protections. A comprehensive patent landscape review, considering related filings, is essential for strategic planning.
Key Takeaways
- CY1126143 claims cover specific chemical compositions, manufacturing methods, and therapeutic uses.
- Claim breadth varies from specific compounds to broader classes, influencing legal strength.
- The patent landscape features related patents in chemical families and therapeutic areas.
- Expiration and continuation strategies will impact long-term market exclusivity.
- Competitor patent activity should inform freedom-to-operate assessments.
FAQs
1. What is the typical lifespan of a pharmaceutical patent like CY1126143?
Twenty years from the earliest filing date, subject to maintenance fees and legal adjustments.
2. Can a patent claim be valid if prior art exists?
Yes, if the claimed invention is novel and non-obvious over prior art, it can be upheld.
3. How does claim breadth affect patent enforcement?
Broader claims offer wider protection but are more vulnerable to invalidation; narrower claims are easier to defend but limit scope.
4. What are common strategies to extend patent protection in pharma?
Filing continuation applications, patent term extensions, and developing secondary patents on formulations or new uses.
5. Why is patent landscape analysis important?
It uncovers potential infringement risks, identifies licensing opportunities, and informs R&D directions.
References (APA Style)
[1] World Intellectual Property Organization. (2022). Patent scope and patent landscape analysis. WIPO Publishing.
[2] USPTO. (2023). Patent terms and maintenance requirements. USPTO.
[3] European Patent Office. (2022). Patent strategies in pharmaceuticals. EPO Patent Guidelines.
